Trump Suspends WHO Funds, Alleges a Poor COVID-19 Response

President Donald Trump claims the World Health Organization failed to investigate early reports of the coronavirus, while public health experts argue that stripping the agency of its funding endangers us all.

Written byAmy Schleunes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, MSEIDELCH

President Donald Trump announced yesterday (April 14) that he is halting funding for the World Health Organization, pending a formal review of the global body’s response to the coronavirus pandemic, reports STAT.

“America and the world have chosen to rely on the WHO for accurate, timely, and independent information to make important public health recommendations and decisions,” Trump said in prepared remarks, according to STAT. “If we cannot trust that this is what we will receive from the WHO, our country will be forced to find other ways to work with other nations to achieve public health goals.”

Devi Sridhar, a global health expert at the University of Edinburgh in the UK, tells Science, “This is a short-sighted decision which will be disastrous for the agency. We need the WHO more than ever to support all countries, especially low and middle income ones.”

Trump said in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies